Solid Pharmaceutical Dosage Form Of Ticagrelor And Acetylsalicylic Acid

Patent No. EP2633857 (titled "Solid Pharmaceutical Dosage Form Of Ticagrelor And Acetylsalicylic Acid") was filed by Ratiopharm on Dec 20, 2010. The application was issued on Aug 12, 2015.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GALENICUM HEALTH SLUMay 12, 2016GALENICUM HEALTH SLU
GENERICS UK TRADING MYLANMay 12, 2016GILL JENNINGS & EVERY
HEXALMay 12, 2016HERZBERG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2633857

RATIOPHARM
Application Number
EP13169378A
Filing Date
Dec 20, 2010
Status
Revoked
Apr 6, 2018
Publication Date
Aug 12, 2015